Centessa Pharmaceuticals PLC ADR CNTA 深 滬
已收盤 02-06 16:00:00 美东时间
23.49
-0.050
-0.21%
華盛通- 最 高24.545
- 今 開23.85
- 成交量 91.68万股
- 最 低 23.33
- 昨 收 23.54
- 總市值 34.31亿
- 52周最高 30.58
- 市盈率 靜 --
- 換手率 0.63%
- 52周最低 9.60
- 委 比 38.33%
- 總股本 1.46亿
- 歷史最高 30.58
- 量 比 0.58
- 振 幅 5.16%
- 歷史最低 2.885
- 每 手 1
- 風險率 5.29%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
Centessa Pharmaceuticals announced its management team will participate in four investor conferences in February and March 2026. The events include Guggenheim Emerging Outlook: Biotech Summit on February 12, TD Cowen 46th Annual Health Care Conference on March 3, Leerink Partners Global Healthcare Conference on March 10, and Jefferies Biotech on the Beach Summit on March 11. Live webcasts and recordings will be available on the company's investor...
02-03 13:00
美股大行评级 | Meta 、IBM、拉姆研究、布林克国际等获多家机构上调目标价；微软、特斯拉、ServiceNow、自动数据处理等遭多家下调评级
今日重点评级关注：Piper Sandler：上调Korro Bio评级至"超配"，目标价从11美元升至30美元；Piper Sandler：维持Nurix Therapeutics"超配"评级，目标价从32美元升至35美元
01-30 17:38
Truist Securities Maintains Buy on Centessa Pharmaceuticals, Raises Price Target to $38
Truist Securities analyst Danielle Brill maintains Centessa Pharmaceuticals (NASDAQ:CNTA) with a Buy and raises the price target from $33 to $38.
01-29 22:56
Nxera Pharma Secures US$3.6 Million Milestone from Centessa Collaboration
The latest announcement is out from Sosei Group ( ($JP:4565) ). Nxera Pharma wi...
01-13 07:52
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
Truist Securities Maintains Buy on Centessa Pharmaceuticals, Raises Price Target to $33
Truist Securities analyst Danielle Brill maintains Centessa Pharmaceuticals (NASDAQ:CNTA) with a Buy and raises the price target from $30 to $33.
01-09 00:48
Oppenheimer’s best small and mid-cap ideas for 2026
Oppenheimer Research released a list of its best ideas for small-caps and mid-caps in the new year. Analysts said that, absent the traditional warning signs that have historically preceded market down...
01-07 00:59
美股大行评级 | 超配！大摩上调回声星通信评级；汽车地带、CBRL、金宝汤、家得宝等遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8美元升至8.25美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12.5美元升至13美元
2025-12-11 10:33
Oppenheimer Maintains Outperform on Centessa Pharmaceuticals, Raises Price Target to $62
Oppenheimer analyst Kostas Biliouris maintains Centessa Pharmaceuticals (NASDAQ:CNTA) with a Outperform and raises the price target from $40 to $62.
2025-12-11 00:36
美股大行评级 | 超配！BETA、BillionToOne获多家机构首予评级；摩根大通上调阿斯麦目标价升至1275美元
今日重点评级关注：RBC Capital：上调Neumora Therapeutics评级至"跑赢大市"，目标价从4美元升至7美元；HC Wainwright & Co.：维持ProMIS Neurosciences"买入"评级，目标价从4美元升至18美元
2025-12-02 09:50
